Literature DB >> 8989230

Sex-related C cell hyperplasia in the normal human thyroid: a quantitative autopsy study.

S Guyétant1, M C Rousselet, M Durigon, D Chappard, B Franc, O Guerin, J P Saint-André.   

Abstract

We report a prospective quantitative image analysis study of C cells in 57 normal autopsy thyroid glands, serially sectioned and wholly embedded in paraffin; all slides were immunohistochemically stained for calcitonin. Computerized quantitative image analysis was performed on 47 cases to measure C cell surface area and parenchymatous surface area after immunoperoxidase staining for calcitonin. The method was time-effective, with a good reproducibility. C cells were mainly found in the middle third of each lobe. Important inter-individual variations were observed; the maximum C cell surface area in a section (Amax) ranged from 28 x 10(3) to 470 x 10(3) microns2 (mean, 167 x 10(3) microns2) among 42 adults. Of particular interest was the important difference observed between sexes; Amax was twice as high in men (mean, 201 x 10(3) microns2) as in women (mean, 91 x 10(3) microns2; P = 0.0009). Moreover, 14 (33%) adult subjects [2 women (15%) and 12 men (41%)] fulfilled C cell hyperplasia criteria, i.e. at least 3 fields at x 100 magnification containing more than 50 C cells, suggesting that a substantial part of the normal adult population could have C cell hyperplasia.

Entities:  

Mesh:

Year:  1997        PMID: 8989230     DOI: 10.1210/jcem.82.1.3684

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Revisiting the Significance of Prominent C Cells in the Thyroid.

Authors:  Talia L Fuchs; Stephen E Bell; A Chou; Anthony J Gill
Journal:  Endocr Pathol       Date:  2019-06       Impact factor: 3.943

Review 2.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 3.  Calcitonin as a biomarker of C cell disease: recent achievements and current challenges.

Authors:  Giuseppe Costante; Domenico Meringolo
Journal:  Endocrine       Date:  2020-01-10       Impact factor: 3.633

4.  Isthmus-preserving total bilobectomy: an adequate operation for C-cell hyperplasia.

Authors:  Robert Arnulf Wahl; Christian Vorländer; Susanne Kriener; Johanna Pedall; Martin Spitza; Martin-Leo Hansmann
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 5.  C-cell hyperplasia and medullary thyroid microcarcinoma.

Authors:  J A Albores-Saavedra; J E Krueger
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

6.  EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma.

Authors:  Luca Giovanella; Giorgio Treglia; Ioannis Iakovou; Jasna Mihailovic; Frederik A Verburg; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-04       Impact factor: 9.236

7.  Glucagon like peptide-1 receptor expression in the human thyroid gland.

Authors:  Belinda Gier; Peter C Butler; Chi K Lai; David Kirakossian; Matthew M DeNicola; Michael W Yeh
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

Review 8.  Thyroid safety in patients treated with liraglutide.

Authors:  M Gallo
Journal:  J Endocrinol Invest       Date:  2013-02       Impact factor: 4.256

9.  Androgen receptor expression in C-cells and in medullary thyroid carcinoma.

Authors:  Qi-Hui Zhai; Katharina Ruebel; Geoffrey B Thompson; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 10.  Is Hashimoto's thyroiditis a risk factor for medullary thyroid carcinoma? Our experience and a literature review.

Authors:  Ayman A Zayed; Moaath K Mustafa Ali; Omar I Jaber; Moh'd J Suleiman; Ashraf A Ashhab; Wajdi Mohammed Al Shweiat; Munther Suliaman Momani; Maha Shomaf; Salah Mohammed AbuRuz
Journal:  Endocrine       Date:  2014-07-24       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.